肝细胞肝癌发病及术后复发与乙肝病毒的相关性研究进展

王小军, 夏锋

王小军, 夏锋. 肝细胞肝癌发病及术后复发与乙肝病毒的相关性研究进展[J]. 实用临床医药杂志, 2009, (3): 25-28. DOI: 10.3969/j.issn.1672-2353.2009.03.007
引用本文: 王小军, 夏锋. 肝细胞肝癌发病及术后复发与乙肝病毒的相关性研究进展[J]. 实用临床医药杂志, 2009, (3): 25-28. DOI: 10.3969/j.issn.1672-2353.2009.03.007
WANG Xiao-jun, XIA Feng. Relativily between outbreak and recrudescence of hepatocellular carcinoma and HBV[J]. Journal of Clinical Medicine in Practice, 2009, (3): 25-28. DOI: 10.3969/j.issn.1672-2353.2009.03.007
Citation: WANG Xiao-jun, XIA Feng. Relativily between outbreak and recrudescence of hepatocellular carcinoma and HBV[J]. Journal of Clinical Medicine in Practice, 2009, (3): 25-28. DOI: 10.3969/j.issn.1672-2353.2009.03.007

肝细胞肝癌发病及术后复发与乙肝病毒的相关性研究进展

基金项目: 国家自然科学基金
详细信息
  • 中图分类号: R735.7

Relativily between outbreak and recrudescence of hepatocellular carcinoma and HBV

  • 摘要: 乙型肝炎病毒的感染是国人肝细胞肝癌发生的主要病因之一.流行病学资料显示已经受乙肝病毒感染的患者,肝细胞肝癌发生的危险性将提高100倍.由慢性乙型肝炎逐步发展成肝硬化,到最后发生癌变是最常见的"三部曲"发病模式.近年来乙肝病毒(HBV)与肝癌的相关性已得到了广泛的关注,现就乙肝病毒及相关组分在肝细胞性肝癌的发生以及术后复发的进程中的作用及其机制作一综述.
  • Kadomatsu K. Recent progress of midkine research on cancer [J]. Japanese Journal of Clinical Medicine, 2000.1337.
    戴利成, 姚行, 陆永良. 肝细胞癌组织中中期因子表达及其与乙型肝炎病毒感染的关系 [J]. 中华医学杂志, 2003, (19):1691.doi: 10.3760/j:issn:0376-2491.2003.19.016.
    Chen C J, Yang H I, Su J. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J]. Journal of the American Medical Association, 2006(1):65.
    Norio Iizuka, Ryouichi Tsunedomi, Takao Tamesa. nvolvement of c-myc-regulated genes in hepatocellular carcinoma related to genotype-C hepatitis B virus [J]. Journal of Cancer Research and Clinical Oncology, 2006, (132):473.doi: 10.1007/s00432-006-0094-8.
    Kubo S, Tamori A, Kazuki O. Previous or Occult Hepatitis B Virus Infection in Hepatitis C Virus-Associated Hepatocellular Carcinoma Without Hepatic Fibrosis [J]. Digestive Diseases and Sciences, 2001, (11):2408.doi: 10.1023/A:1012359400193.
    Rabe C, Cheng B, Caselmann W H. Molecular mechanisms of hepatitis B virus-associated liver cancer [J]. Digestive Diseases, 2001, (19):279.doi: 10.1159/000050694.
    Madden C R, Finegold M J, Slagle B L. Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions [J]. Journal of Virology, 2001, (75):3851.doi: 10.1128/JVI.75.8.3851-3858.2001.
    Jia L X, Wang X W. Harris CC Hepatitis B virus X protein inhibits nucleotide excision repair [J]. International Journal of Cancer, 1999, (80):875.
    ZY Gao, T Li, J Wang. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma [J]. Gastroenterology, 2007, (9):761.doi: 10.1007/s00535-007-2085-1.
    Yang H I, Lu S N, Liaw Y F. Hepatitis Be antigen and the risk of hepatocellular carcinoma [J]. New England Journal of Medicine, 2002(3):168.doi: 10.1056/NEJMoa013215.
    Lebret T, Watson R W, Molinie V. Heat shock proteins HSP27, HSP60, HSP70, and HSP90:expression in bladder carcinoma [J]. Cancer, 2003, (5):970.doi: 10.1002/cncr.11594.
    Lim S O, Park S G, Yoo J H. Expression of heat shock proteins(HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules [J]. World Journal of Gastroenterology, 2005, (14):2072.
    Kubo S, Tanaka H, Tanaka H. Effect of viral status on recurrence after liver resection for patients with hepatitis B virus related hepatocllular carcinoma [J]. Cancer, 2000(5):1016.doi: 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V.
    HCSun, ZY Tang, ZC Ma. The prognostic factor for outcome following second for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background [J]. Journal of Cancer Research and Clinical Oncology, 2005, (5):284.doi: 10.1007/s00432-004-0645-9.
    杨晓静, 邹雄, 王谦. 慢性乙肝和肝癌患者HLA2DR 抗原在外周血淋巴细胞亚群中的表达分析 [J]. 上海免疫学杂志, 2003(1):59.doi: 10.3969/j.issn.1001-2478.2003.01.019.
    黄团新, 周永兴, 韩秀珍. 肝炎肝硬化及原发性肝癌患者外周血T 淋巴细胞亚群分析 [J]. 临床内科杂志, 2001, (1):79.doi: 10.3969/j.issn.1001-9057.2001.01.031.
    Stoop J N, van derMolen R G, Baan C C. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection [J]. Hepatology, 2005, (14):700.
    Dieckmann D, Plottnar H, Berchtold S. Ex vivo isolation and characterization of CD4(+)CD25(+) T cell with regulatory properties from human blood [J]. Journal of Experimental Medicine, 2001, (11):1303.doi: 10.1084/jem.193.11.1303.
    Hideo Y, Haruhiko Y, Eriko G. Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma [J]. Hepatol Int, 2008.89.
计量
  • 文章访问数: 
  • HTML全文浏览量: 
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 发布日期:  2009-04-14

目录

    /

    返回文章
    返回
    x 关闭 永久关闭